Non-viral delivery of ribozymes for cancer gene therapy.
about
PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategyVEGF/VEGFR signalling as a target for inhibiting angiogenesis.Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
P2860
Non-viral delivery of ribozymes for cancer gene therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Non-viral delivery of ribozymes for cancer gene therapy.
@ast
Non-viral delivery of ribozymes for cancer gene therapy.
@en
type
label
Non-viral delivery of ribozymes for cancer gene therapy.
@ast
Non-viral delivery of ribozymes for cancer gene therapy.
@en
prefLabel
Non-viral delivery of ribozymes for cancer gene therapy.
@ast
Non-viral delivery of ribozymes for cancer gene therapy.
@en
P2860
P1476
Non-viral delivery of ribozymes for cancer gene therapy.
@en
P2093
Mohammed Kashani-Sabet
P2860
P304
P356
10.1517/14712598.4.11.1749
P407
P577
2004-11-01T00:00:00Z